Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, a novel approach that we have pioneered. Our approach, called Immune System Programming (ISP™) entails collecting a type of the patient’s immune cells, called B cells. In response...
Total raised: $30.59M
Founded date: 2009
Investors 6
Date | Name | Website |
- | Taihill Ve... | taihill.vc |
- | Global Sou... | globalsour... |
06.09.2022 | Skylight I... | skylightin... |
- | Breakout L... | breakoutla... |
- | Breakout V... | breakout.v... |
- | Grand Ange... | michiganca... |
Funding Rounds 5
Date | Series | Amount | Investors |
25.09.2020 | - | $4.5M | - |
04.01.2019 | Series B | $20M | - |
05.01.2018 | Series B | $3M | - |
11.11.2016 | - | $2.74M | - |
21.04.2012 | Grant | $350K | - |
Mentions in press and media 19
Date | Title | Description | Source |
29.01.2023 | Immusoft Receives $8M in Funding from the California Institu... | Immusoft of CA, a San Francisco, CA-based wholly owned subsidiary of Immusoft Corporation, a clinica... | finsmes.co... |
01.09.2022 | Seattle biotech company is the first to receive approval to ... | Immusoft’s steps to delivering a treatment using engineered B cells. (Screen grab from Immusoft’s we... | geekwire.c... |
29.11.2021 | Immusoft Receives $4M in Funding from the California Institu... | Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated ... | marketscre... |
14.10.2021 | Cell therapy startup Immusoft lands deal with Takeda worth p... | Immusoft CEO Sean Ainsworth. (Immusoft Photo) Seattle-based cell therapy startup Immusoft will coll... | geekwire.c... |
25.09.2020 | Seattle gene therapy biotech startup Immusoft raises $4.5M | Seattle-based biotech startup Immusoft raised another $4.5 million and landed a $467,000 NIH grant t... | geekwire.c... |
04.01.2019 | Seattle biotech startup raises $20M to develop gene therapy ... | Immusoft CEO Sean Ainsworth. (Immusoft Photo) Seattle-based biotech startup Immusoft this week clos... | geekwire.c... |
04.01.2019 | Seattle Startup Funding News: Immusoft, TurboPatent, VYRTY &... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Catch up on funding news in the Se... | xconomy.co... |
04.01.2019 | Top startup news for today, Friday, January 4, 2019 | Good morning! Here are some of the top technology startup news stories for today, Friday, January 4,... | techstartu... |
04.01.2019 | Immusoft Raises $20M in Series B Financing | Immusoft Corporation, a Seattle-Wash.-based cell therapy company, held the final closing in its $20m... | finsmes.co... |
03.01.2019 | Immusoft Receives $20M Series B Round | SEATTLE, WA, Immusoft, a cell therapy company, announced today it has held the final closing in it... | vcnewsdail... |
Show more